Home » Press Release » Archive by category "2013"

November 27, 2013

Alethia Biotherapeutics announces the issuance of patent EP2032701  entitled “Polynucleotides and polypeptide sequences involved in cancer ” by the European Patent Office

November 12, 2013

Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,580,257  entitled “Antibodies that specifically block the biological activity of kidney associated antigen 1 (KAAG1)” by the United States Patent and Trademark Office (“USPTO”)

October 9, 2013

Alethia Biotherapeutics Announces the Issuance of a Patent for the Use of Anti-Siglec-15 Antibodies

Alethia PR 131009 EN

May 16, 2013

Alethia Biotherapeutics Announces the Issuance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT

Alethia 130516 EN

February 28, 2013

Alethia Biotherapeutics Announces Notice of Allowance of a United States Patent for Monoclonal Antibodies Targeting Secreted Clusterin for Inhibition of EMT

Alethia 130228 EN

February 19, 2013

Alethia Biotherapeutics Announces Issuance of a Japanese Patent for Monoclonal Antibodies Targeting Siglec-15

Alethia 130219 EN